Dr. Pipe, a speaker in the Special Education Session on Newly Approved Drugs, reviews what clinicians need to know about coagulation factor IX (recombinant)/antihemophilic factor (recombinant) as bleeding prophylaxis in patients with hemophilia.
Skip Nav Destination
Steven Pipe, MD: Changing the Delivery of Bleeding Prevention for Hemophilia Patients
December 30, 2021
Content License:Private